secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEKTAR THERAPEUTICS (NKTR)
CIK:        0000906709
Form:       8-K
Filed at:   2025-06-27T23:59:59+00:00
Accession:  0001213900-25-059115
Event type: regulatory
Sentiment:  positive
Materiality: 0.55
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Nektar Therapeutics regains Nasdaq minimum bid price compliance
---------------------------------------------------------------

- Received Nasdaq deficiency notice on April 3, 2025 for bid price below $1.00.
- Regained compliance on June 23, 2025 after 10 consecutive trading days above $1.00.
- Nasdaq confirmed compliance in a letter dated June 24, 2025.
- Company continues to trade on The Nasdaq Capital Market under symbol NKTR.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/906709/000121390025059115/0001213900-25-059115-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/906709/000121390025059115/ea0247333-8k_nektar.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-059115

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer